SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-006053
Filing Date
2024-03-01
Accepted
2024-03-01 15:06:55
Documents
2
Period of Report
2024-02-28

Document Format Files

Seq Description Document Type Size
1 form4-03012024_080349.html 4  
1 form4-03012024_080349.xml 4 7321
2 ex24-03012024_080349.htm EX-24 7716
  Complete submission text file 0001415889-24-006053.txt   16466
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BLUEPRINT MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address
Murray Christopher K. (Reporting) CIK: 0001718648 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 24709080